Yang Zhou Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

John Brown University

faculty

34 h-index 121 pubs 3,699 cited

Research Areas

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Adenosine and Purinergic Signaling Studies on Chitinases and Chitosanases Neonatal Respiratory Health Research Neuroinflammation and Neurodegeneration Mechanisms Influenza Virus Research Studies Chronic Kidney Disease and Diabetes

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Dr. Yang Zhou at John Brown University conducts research spanning diverse areas of biomedicine, from lung disease to neuroinflammation. Zhou's work addresses the pathogenesis and treatment of interstitial lung diseases and idiopathic pulmonary fibrosis, with a focus on novel drug delivery strategies. Zhou also investigates the roles of chitinases and chitosanases in disease, including the therapeutic potential of targeting chitinase 3-like-1 in both COVID-19 and pulmonary hypertension. Additional projects include neonatal respiratory health, neurodegeneration mechanisms, influenza virus, and the links between chronic kidney disease and diabetes. A recent publication explores the role of CPR63 in pyrethroid resistance in mosquitos.

Metrics

  • h-index: 34
  • Publications: 121
  • Citations: 3,699

Selected Publications

  • Phospholipid Scramblase 1 (PLSCR1) Regulates Interferon-Lambda Receptor 1 (IFN-λR1) and IFN-λ Signaling in Influenza A Virus (IAV) Infection (2025) DOI
  • Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection (2025) DOI
  • Phospholipid Scramblase 1 (PLSCR1) Regulates Interferon-Lambda Receptor 1 (IFN-λR1) and IFN-λ Signaling in Influenza A Virus (IAV) Infection (2025) DOI
  • Phospholipid Scramblase 1 (PLSCR1) Regulates Interferon-Lambda Receptor 1 (IFN-lambdaR1) and IFN-lambda Signaling in Influenza A Virus (IAV) Infection (2024) DOI
  • Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19 (2022) DOI

Collaborators

Researchers in the database who share publications

Parand Sorkhdini John Brown University 14 shared publications Alina X Yang John Brown University 11 shared publications Carmelissa Norbrun John Brown University 10 shared publications Dongqin Yang John Brown University 6 shared publications Sonoor Majid John Brown University 6 shared publications Sang-Hyun Lee John Brown University 3 shared publications Sang-Hyun Lee John Brown University 3 shared publications Olin D. Liang John Brown University 2 shared publications

Similar Researchers

Based on overlapping research topics

Roberto Cotez John Brown University
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Studies on Chitinases and Chitosanases
Good match
J. Cheney University of Arkansas for Medical Sciences
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Neonatal Respiratory Health Research
Related
Chuan-Hua He John Brown University
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Studies on Chitinases and Chitosanases
Related
Jin Wook Park John Brown University
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Studies on Chitinases and Chitosanases
Related
K. Pece Henderson State University
Adenosine and Purinergic Signaling
Related
Billy Thomas University of Arkansas for Medical Sciences
Neonatal Respiratory Health Research Chronic Kidney Disease and Diabetes
Related